Table 11 Assessment of responsiveness of the EQ-5D-3L and the EQ-5D-5L measures to changes in the Barthel Index, for the subgroup in Switzerland
EQ-5D-3L at 6 months (mean) | EQ-5D-3L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-3L (95% CI) | Effect size (Cohen’s D)a | n | % reporting 3L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.41 | 0.79 | 0.38 (0.04 to 0.71) | 1.63* | 4 | 100 |
No change | 0.93 | 0.89 | − 0.03 (− 0.10 to 0.02) | − 0.23 | 39 | 15 |
Worsened | 0.84 | 0.70 | − 0.13 (− 0.30 to 0.02) | − 0.54 | 12 | 17 |
EQ-5D-5L at 6 months (mean) | EQ-5D-5L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-5L (95% CI) | Effect size (Cohen’s D) | n | % reporting 5L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.40 | 0.73 | 0.32 (0.01 to 0.63) | 1.49 | 4 | 100 |
No change | 0.91 | 0.90 | − 0.01 (− 0.05 to 0.02) | − 0.11 | 39 | 15 |
Worsened | 0.78 | 0.71 | − 0.06 (− 0.20 to 0.07) | − 0.28 | 12 | 33 |